Hsin Yeh

Title: Hsin Yeh - Innovator in Immunomodulatory Proteins

Introduction

Hsin Yeh is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of immunomodulatory proteins aimed at combating coronavirus diseases. His innovative work is crucial in the ongoing fight against viral infections.

Latest Patents

Hsin Yeh holds a patent for an "Immunomodulatory protein for alleviation and/or treatment of coronavirus diseases." This patent describes a method for alleviating and/or treating a coronavirus disease in a subject in need thereof. The method includes administering an effective amount of immunomodulatory protein, a recombinant thereof, or a fragment thereof to the subject. This patent highlights his commitment to advancing medical science and improving public health.

Career Highlights

Hsin Yeh is associated with Mycomagic Biotechnology Co., Ltd., where he applies his expertise in biotechnology to develop innovative solutions. His work at the company reflects his dedication to research and development in the field of immunology.

Collaborations

Hsin Yeh collaborates with talented individuals such as Tung-Yi Lin and Zhi-Hu Lin. These partnerships enhance the research and development efforts at Mycomagic Biotechnology Co., Ltd., fostering an environment of innovation and creativity.

Conclusion

Hsin Yeh's contributions to the field of biotechnology, particularly through his patent on immunomodulatory proteins, demonstrate his role as a key innovator in addressing health challenges. His work continues to inspire advancements in medical treatments and therapies.